Sleep, cognition & neuro
DSIP
Written by the Elevate Clinical Team
Citations independently verified against PubMed, ClinicalTrials.gov, and FDA sources on . Independent clinical review pending.
Also known as Delta Sleep-Inducing Peptide
A neuropeptide studied for its effect on slow-wave sleep architecture and stress response.
What it is
DSIP was isolated from rabbit brain during sleep induction and named for the delta-wave activity it appeared to promote. Decades later its mechanism is still poorly defined, and the human literature is small and mixed.
What it's studied for
- Slow-wave sleep in early human and animal studies
- Chronic insomnia in small trials
- Stress-hormone and pain-perception research
How it's used in practice
- Sleep hygiene, alcohol, light exposure and cortisol rhythm outrank any compound here
- Sleep disruption in midlife is frequently hormonal, not a sleep-drug problem
What you should know before asking about it
- Research use only; not FDA-approved
- Sparse and inconsistent human data
- Untreated sleep apnea is a diagnosis, not something to medicate around
Frequently asked questions.
- What is DSIP?
- DSIP was isolated from rabbit brain during sleep induction and named for the delta-wave activity it appeared to promote. Decades later its mechanism is still poorly defined, and the human literature is small and mixed.
- What is DSIP studied for?
- Published and ongoing research looks at slow-wave sleep in early human and animal studies; chronic insomnia in small trials; stress-hormone and pain-perception research. These are areas of study, not promised outcomes.
- Is DSIP FDA-approved?
- DSIP has not been evaluated by the FDA. Elevate Chicago lists it for education and research reference only — it is not prescribed as medical care and is not intended for human consumption.
- How is DSIP typically used?
- Sleep hygiene, alcohol, light exposure and cortisol rhythm outrank any compound here Sleep disruption in midlife is frequently hormonal, not a sleep-drug problem Any specific dose, frequency or duration comes from a prescription written for you after labs — never from this page.
- What are the risks and unknowns with DSIP?
- Research use only; not FDA-approved Sparse and inconsistent human data Untreated sleep apnea is a diagnosis, not something to medicate around
Sources
- 1.Published literature on DSIP Delta Sleep-Inducing Peptide— PubMed, U.S. National Library of Medicine
- 2.Compounding and the FDA: questions and answers— U.S. Food & Drug Administration
- 3.Bulk drug substances nominated for use in compounding under section 503A— U.S. Food & Drug Administration
- 4.Test directory and patient service center locator— Quest Diagnostics
About this page
Written by the Elevate Clinical Team
Citations independently verified against PubMed, ClinicalTrials.gov, and FDA sources on . Independent clinical review pending. Educational content only — not medical advice, not a diagnosis, and not an offer to sell any prescription product.
This page is educational reference material. It is not medical advice, not a diagnosis, and not an offer to sell any product. Prescription therapies are dispensed only through licensed, FDA-registered compounding pharmacies after a physician evaluation. Compounds identified as research use only are not FDA-approved, are not prescribed as medical care, and are not intended for human or animal consumption. Availability, formulations and regulatory status change over time.
More in Sleep, cognition & neuro
Selank
A synthetic analog of the immunopeptide tuftsin studied for anxiolytic and stress-response effects.
Semax
An ACTH(4-10) analog studied for attention, memory and neuroprotection.
Dihexa
An angiotensin IV analog studied for synapse formation via hepatocyte growth factor signaling.